Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 22,951 shares at $43.66 ($1.0M) on 2026-04-14, disclosed to the SEC on 2026-04-15.
Scheduled sale ($1.0M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.66 | 14,130 | $617K | 61.0% |
| 2 | $44.58 | 7,921 | $353K | 34.9% |
| 3 | $45.51 | 900 | $41K | 4.1% |
| Total | $44.05 avg | 22,951 | $1.0M | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-06-24 | $702K | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |